Skip to main content
logo
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
21.66
+0.62 (2.95%)
At close: Feb 2, 2026, 4:00 PM EST
21.66
0.00 (0.00%)
After-hours: Feb 2, 2026, 7:00 PM EST

Arcus Biosciences Revenue

Arcus Biosciences had revenue of $26.00M in the quarter ending September 30, 2025, a decrease of -45.83%. This brings the company's revenue in the last twelve months to $240.00M, down -8.75% year-over-year. In the year 2024, Arcus Biosciences had annual revenue of $258.00M with 120.51% growth.

Revenue (ttm)
$240.00M
Revenue Growth
-8.75%
P/S Ratio
9.09
Revenue / Employee
$382,775
Employees
627
Market Cap
2.68B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024258.00M141.00M120.51%
Dec 31, 2023117.00M5.00M4.46%
Dec 31, 2022112.00M-271.00M-70.76%
Dec 31, 2021383.00M305.00M391.03%
Dec 31, 202078.00M63.00M420.00%
Dec 31, 201915.00M6.65M79.58%
Dec 31, 20188.35M6.94M491.15%
Dec 31, 20171.41M--
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Apellis Pharmaceuticals1.02B
Telix Pharmaceuticals664.23M
Travere Therapeutics435.83M
Tarsus Pharmaceuticals366.10M
Adaptive Biotechnologies252.75M
IDEAYA Biosciences214.83M
Wave Life Sciences109.23M
Beam Therapeutics55.70M
Revenue Rankings

RCUS News

More News